Journal article

Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies

Timothy J Key, Paul N Appleby, Ruth C Travis, Demetrius Albanes, Anthony J Alberg, Aurelio Barricarte, Amanda Black, Heiner Boeing, H Bas Bueno-de-Mesquita, June M Chan, Chu Chen, Michael B Cook, Jenny L Donovan, Pilar Galan, Rebecca Gilbert, Graham G Giles, Edward Giovannucci, Gary E Goodman, Phyllis J Goodman, Marc J Gunter Show all

The American Journal of Clinical Nutrition | AMER SOC NUTRITION-ASN | Published : 2015

Grants

Awarded by Cancer Research UK


Awarded by US Public Health Service from the National Cancer Institute, Department of Health and Human Services


Awarded by NIH, Department of Health and Human Services


Awarded by National Cancer Institute, NIH


Awarded by National Cancer Institute


Awarded by NIH


Awarded by Australian National Health and Medical Research Council


Awarded by United Kingdom National Institute for Health Research Health Technology Assessment Programme


Awarded by Medical Research Council


Awarded by National Institute for Health Research


Funding Acknowledgements

Supported by Cancer Research UK grants C8221/A19170 and C570/A11691, Funding for the collaborating studies was as follows. Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: Supported in part by the Intramural Research Program of the NIH and the National Cancer Institute; also, this research was supported by US Public Health Service contracts N01-CN-45165, N01-RC-45035, N01-RC-37004, and HHSN261201000006C from the National Cancer Institute, Department of Health and Human Services. beta-Carotene and Retinol Efficacy Trial: Supported by U01 CA63673, R01 CA96789, and N01 PC35142, all from the NIH, Department of Health and Human Services. CLUE I and II: Supported by CA 94028 from the National Cancer Institute, NIH. European Prospective Investigation into Cancer and Nutrition Greece: Supported by the Hellenic Health Foundation. European Prospective Investigation into Cancer and Nutrition Netherlands: Supported by the Dutch Ministry of Public Health, Welfare and Sports (VWS), Netherlands Cancer Registry (NKR), LK Research Funds, Dutch Prevention Funds, Dutch Zorg Onderzoek Nederland, World Cancer Research Fund, Statistics Netherlands. Health Professionals Follow-Up Study: Supported by CA 55075 and CA 72036 from the National Cancer Institute and the NIH. Janus: The serum analysis of vitamins was supported by a grant from the Norwegian Cancer Society and the Throne Hoist Foundation. Melbourne Collaborative Cohort Study (MCCS): Cohort recruitment was funded by VicHealth and Cancer Council Victoria. The MCCS was further supported by Australian National Health and Medical Research Council grants 209057, 251553, and 504711 and by infrastructure provided by Cancer Council Victoria. Multiethnic Cohort: Supported by National Cancer Institute grants P01 CA 33619, R37 CA 54281, and 1-UM1-CA164973. Prostate Cancer Prevention Trial: Supported by National Cancer Institute and NIH, CA37429 and P01 CA108964. Prostate testing for cancer and Treatment trial: Funded by the United Kingdom National Institute for Health Research Health Technology Assessment Programme (projects 96/20/06, 96/20/99, www.hta/1230); the views and opinions expressed therein are those of the authors and do not necessarily reflect those of the Department of Health. The University of Bristol Integrated Epidemiology Unit is supported by the Medical Research Council and the University of Bristol. The Bristol Nutrition Biomedical Research Unit is funded by the National Institute for Health Research and is a partnership between the University Hospitals Bristol National Health Service Foundation Trust and the University of Bristol. SU.VI.MAX, SUpplementation en VItamines et Mineraux Anti-oXydants trial: Supported by the Direction Generale de la Sante (French Ministry of Health) for laboratory assays.